Market Overview

Benzinga's Top Downgrades

Benzinga's Top Downgrades
Related AXS
UPDATE: AXIS Capital Agrees to Terminate Merger with PartnerRe and Receives $315M Breakup Fee
Benzinga's M&A Chatter for Wednesday July 29, 2015
AXIS Capital cutting jobs (Seeking Alpha)
Related THRX
Glaxosmithkline, Theravance Intend to File Relvar Ellipta for COPD in Japan
Theravance Just Lost Its Catalyst

Analysts at Goldman Sachs downgraded Axis Capital Holdings (NYSE: AXS) from “neutral” to “sell.” The target price for Axis Capital has been lowered from $44 to $43. Axis Capital's shares closed at $46.34 yesterday.

Stifel Nicolaus downgraded Theravance (NASDAQ: THRX) from “buy” to “hold” and removed the price target of $37.86. Theravance's shares closed at $26.40 yesterday.

Sterne Agee downgraded SpringLeaf Holdings (NYSE: LEAF) from “buy” to “neutral.” The target price for SpringLeaf has been lowered from $30 to $28. SpringLeaf's shares closed at $26.49 yesterday.

Analysts at KeyBanc downgraded Computer Programs and Systems (NASDAQ: CPSI) from “hold” to “underweight.” The price target for Computer Programs is set to $55. Computer Programs' shares closed at $65.70 yesterday.

Latest Ratings for AXS

Sep 2015Sterne Agee CRTInitiates Coverage onNeutral
Aug 2015Morgan StanleyAssumesEqual-weight
Aug 2015Keefe Bruyette & WoodsMaintainsOutperform

View More Analyst Ratings for AXS
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (CPSI + AXS)

View Comments and Join the Discussion!

Get Benzinga's Newsletters